Data Normalization vs. Standardization is one of the most foundational yet often misunderstood topics in machine learning and data preprocessing. If you’ve ever built a predictive model, worked on a ...

The Dow Jones Industrial Average closed above 50,000 points for the first time on Friday as stocks rallied in response to a rout in tech shares earlier in the week. The closely watched index rose ...

For a brief moment, the digital asset treasury (DAT) was Wall Street’s bright, shiny object. But in 2026, the novelty has worn off. The star of the “passive accumulator” has dimmed, and rightly so.

Sarina Trangle started as a corporate news reporter in October 2024. She previously spent four years on the business desk at Newsday, covering the health industry, commercial real estate and cannabis.

SQL Server 2025 reaches enterprise readiness with GA support on RHEL 10 and Ubuntu 24.04. Cumulative Update 1 improves SQL Server 2025 reliability, performance and security based on early feedback.

It has been almost a year since President Donald Trump took office for the second time, promising at his inauguration, “During every single day of the Trump administration, I will, very simply, put ...

The yield on 10-year Japanese government bonds breached the 2% mark for the first time since 1999. BOJ: Real interest rates are expected to remain "significantly negative." BOJ: While weakness has ...

Dec. 16 (Asia Today) --"Decade of the Spy" was a label used by U.S. media in the 1980s, when major espionage cases involving the former Soviet Union were uncovered year after year. In 2025, the phrase ...

Hosted by actor Kevin Costner, this special explores the origins of Christmas with a dramatized version of the nativity story. Gia Patel stars as Mary, while Ethan Thorne plays Joseph. Corinne Furman, ...

The special event is airing on Tuesday, Dec. 9 at 8 p.m. You can watch live as it airs on DirecTV (free trial) or Fubo TV (free trial). It will be available the next day on Disney+ and Hulu. The ...

The Company plans to initiate a Phase 3 program evaluating INCA033989 in essential thrombocythemia (ET) patients with all types of CALR mutations in mid-2026, following alignment with regulators ...